Rare diseases
Investigational molecules
Locations
Back to Italy2 655 clinical trials in Varese, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyStudy of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ItalyStudy of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation
ItalyStudy of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment
ItalyStudy of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia
ItalyStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with Advanced HER2-Positive Breast Cancer
ItalyStudy of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer
ItalyStudy Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma
ItalyStudy on the Safety and Effectiveness of Crinecerfont for Children with Classic Congenital Adrenal Hyperplasia
ItalyStudy of Pegcetacoplan (APL-2) in Patients with Transplant-associated Thrombotic Microangiopathy After Stem Cell Transplantation
ItalyStudy of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant
ItalyStudy on Carbetocin Nasal Spray for Reducing Uncontrollable Hunger in Patients with Prader-Willi Syndrome
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood cancers and lymphomas, including studies of novel therapies for acute myeloid leukemia and chronic myeloid leukemia. Clinical trials are evaluating innovative treatment combinations and maintenance strategies.
Investigations include maintenance therapies and comparison of shortened versus standard chemotherapy protocols combined with immunotherapy.
Comprehensive studies on non-small cell lung cancer and pleural mesothelioma, exploring innovative combination therapies and targeted treatments for specific genetic mutations.
Research focuses on personalized treatment approaches and novel drug combinations to improve patient outcomes.
Advanced research in cardiovascular disease and thrombosis, with trials examining innovative treatments for reducing cardiovascular events and managing blood clots.
Studies aim to evaluate new therapeutic approaches for preventing major cardiovascular events and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
